Peptide Bioregulator

How Peptide Bioregulators Work

According to bioregulator theory, these peptides function through:

1. DNA interaction - Short peptides enter cells and interact with specific DNA sequences
2. Gene regulation - Modulate transcription of tissue-specific genes
3. Protein synthesis - Influence production of proteins relevant to organ function
4. Tissue restoration - Help restore optimal function to aged or damaged tissues
5. Information transfer - Carry “regulatory information” from healthy to damaged cells

This mechanism is distinct from traditional peptide receptor binding and remains an area of ongoing research.

Relevance to Peptides

Peptide bioregulators represent a unique approach to peptide therapy developed primarily in Russia over 40+ years.

Key Bioregulator Peptides

Bioregulator	Target Organ	Amino Acids	Research Focus
Epithalon	Pineal gland	4 (AGAG)	Telomerase, aging
Thymalin	Thymus	Complex	Immune function
Cortexin	Brain	Complex	Cognitive function
Retinalamin	Retina	Complex	Vision, eye health
Prostatilen	Prostate	Complex	Prostate health

Natural vs Synthetic Bioregulators

Cytogens (Natural extracts)

• Derived from animal tissues
• Complex peptide mixtures
• Standardized by peptide content

Cytoamines (Synthetic)

• Defined short peptide sequences
• Higher purity and consistency
• Epithalon is the most well-known example

The Khavinson Research

Professor Vladimir Khavinson developed bioregulator theory over decades:

• 1970s-80s - Initial research in Soviet military applications
• 1990s - Establishment of St. Petersburg Institute of Bioregulation
• 2000s - Published research on epithalon and telomerase
• Present - Ongoing studies on aging and tissue regeneration

Over 200 peptide bioregulators have been catalogued for various organ systems.

Bioregulator Categories

Neuroregulators

• Cortexin - Brain/cortex
• Pinealon - Pineal gland (synthetic)
• Cerluten - Brain (synthetic)

Immunoregulators

• Thymalin - Thymus gland
• Thymogen - Thymus (synthetic dipeptide)
• Crystagen - Immune system (synthetic)

Organ-Specific

• Cardiogen - Heart
• Livagen - Liver
• Vesugen - Vascular system
• Testagen - Testes

Research Status

Aspect	Status
Russian regulatory approval	Some approved (Thymalin, Cortexin)
FDA approval	None
Peer-reviewed research	Limited Western studies
Clinical trials	Primarily Russian/Eastern European
Mechanism validation	Ongoing, debated

Frequently Asked Questions

Are bioregulators proven to work?

Bioregulator research comes primarily from Russian institutions, with limited Western replication of findings. While some studies show promising results, the proposed mechanism of DNA interaction by short peptides is not widely accepted in mainstream pharmacology. More independent research is needed.

How are bioregulators different from other peptides?

Traditional peptides typically work through receptor binding on cell surfaces. Bioregulators are proposed to work by entering cells and directly interacting with DNA to regulate gene expression. This mechanism, while not universally accepted, represents a distinct theoretical framework.

Are bioregulators safe?

Bioregulators have been used in Russia for decades with reported safety profiles. However, Western clinical trial data is limited. The short peptide sequences are generally considered to have low toxicity risk, but long-term studies in diverse populations are lacking.

What is the difference between Cytogens and Cytoamines?

Cytogens are natural peptide extracts from animal tissues containing complex peptide mixtures. Cytoamines are synthetic peptides with defined sequences. Cytoamines offer more consistency and purity but may not contain all the active components found in natural extracts.